Trial Profile
A Prospective Study of Patterns, Predictors, and Mechanisms of Weight Loss With Exenatide Treatment in Overweight and Obese Women Without Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 25 Jun 2021
Price :
$35
*
At a glance
- Drugs Exenatide (Primary)
- Indications Obesity
- Focus Therapeutic Use
- 30 Apr 2020 Status changed from active, no longer recruiting to completed.
- 04 Feb 2020 Planned End Date changed from 1 Dec 2019 to 1 Feb 2020.
- 11 Sep 2019 Planned End Date changed from 1 Jul 2019 to 1 Dec 2019.